Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON-HF trial.
Henri LuBrian L ClaggettMilton PackerMarc A PfefferCarolyn S P LamMichael R ZileAkshay S DesaiPardeep JhundMartin LefkowitzJohn J V McMurrayScott D SolomonMuthiah VaduganathanPublished in: European journal of heart failure (2024)
ClinicalTrials.gov ID NCT01920711.